WorldPolicy change Affects United Kingdom and Israel

Second UK Health Body Ends Sponsorship With Israeli Drugmaker

Published 1d ago · Latest report 2h ago

Covered in 2 countries

AI summary35s readNegative

A second British health organization dropped Israeli drugmaker Teva following activist pressure.

The Royal College of Pharmacy terminated its sponsorship agreement with Israeli pharmaceutical company Teva following pressure from pro-Palestinian activists. This move follows a similar decision by another British medical organization to sever financial ties with the firm over its corporate activities.

  • The pressureActivists and medical professionals targeted the pharmaceutical firm over its ties to Israel.
  • The reactionNHS doctors and campaigners urged other healthcare institutions to follow suit and end similar financial arrangements.

Why it matters

Healthcare organizations face growing scrutiny over corporate sponsorships and ethical investments amid ongoing geopolitical conflicts in the Middle East. Medical bodies are increasingly pressured by staff and activist groups to sever ties with companies operating in or linked to contested regions.

What outlets agree on

The Royal College of Pharmacy ended its sponsorship agreement with Teva Pharmaceuticals after facing pressure from pro-Palestinian campaigners concerned about the company's activities.

Tune your feed
Reactions

In this story

Covered by 2 outlets

100% of the sources are Left

Lean ratings via Media Bias/Fact Check, AllSides

Are you a publisher? Tell us how we may use your content

Similar stories

More on Teva →

What people are saying

Opens a search on that site in a new tab. Posts there are not ours and are not checked.

The headline, summary and key points are AI-generated from the sources above.

Comments